These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9395356)

  • 1. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.
    Murphy EL; Glynn SA; Fridey J; Sacher RA; Smith JW; Wright DJ; Newman B; Gibble JW; Ameti DI; Nass CC; Schreiber GB; Nemo GJ
    J Infect Dis; 1997 Dec; 176(6):1468-75. PubMed ID: 9395356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.
    Murphy EL; Glynn SA; Fridey J; Smith JW; Sacher RA; Nass CC; Ownby HE; Wright DJ; Nemo GJ
    Arch Intern Med; 1999 Jul; 159(13):1485-91. PubMed ID: 10399901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.
    Murphy EL; Wang B; Sacher RA; Fridey J; Smith JW; Nass CC; Newman B; Ownby HE; Garratty G; Hutching ST; Schreiber GB
    Emerg Infect Dis; 2004 Jan; 10(1):109-16. PubMed ID: 15078605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.
    Murphy EL; Fridey J; Smith JW; Engstrom J; Sacher RA; Miller K; Gibble J; Stevens J; Thomson R; Hansma D; Kaplan J; Khabbaz R; Nemo G
    Neurology; 1997 Feb; 48(2):315-20. PubMed ID: 9040713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.
    Moreira ED; Ribeiro TT; Swanson P; Sampaio Filho C; Melo A; Brites C; Badaró R; Toedter G; Lee H; Harrington W
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):959-63. PubMed ID: 8315579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.
    Vermeulen M; Sykes W; Coleman C; Custer B; Jacobs G; Jaza J; Kaidarova Z; Hlela C; Gessain A; Cassar O; Poole C; Ingram C; Murphy EL; Reddy R
    Vox Sang; 2019 Jul; 114(5):451-458. PubMed ID: 30950074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru.
    Verdonck K; González E; Henostroza G; Nabeta P; Llanos F; Cornejo H; Vanham G; Seas C; Gotuzzo E
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1066-72. PubMed ID: 17945062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
    San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
    J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau.
    Norrgren H; Andersson S; Nauclér A; Dias F; Johansson I; Biberfeld G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):422-8. PubMed ID: 7600111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
    Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors.
    Guiltinan AM; Kaidarova Z; Behan D; Marosi C; Hutching S; Kaiser M; Moore E; Devita D; Murphy EL;
    Transfusion; 2013 Jan; 53(1):60-8. PubMed ID: 22554308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.
    Biswas HH; Engstrom JW; Kaidarova Z; Garratty G; Gibble JW; Newman BH; Smith JW; Ziman A; Fridey JL; Sacher RA; Murphy EL
    Neurology; 2009 Sep; 73(10):781-9. PubMed ID: 19738173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users.
    Schwebke J; Calsyn D; Shriver K; Saxon A; Kleyn J; Oluoch-Mitchell E; Olmstead L; Fisher LD; Krone M; Ashley R
    J Infect Dis; 1994 May; 169(5):962-7. PubMed ID: 8169427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
    Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
    Stigum H; Magnus P; Samdal HH; Nord E
    Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.
    Treviño A; García J; de Mendoza C; Benito R; Aguilera A; Ortíz de Lejarazu R; Ramos JM; Trigo M; Eirós JM; Rodríguez-Iglesias M; Torres A; Calderón E; Hernandez A; Gomez C; Marcaida G; Soriano V;
    AIDS Res Hum Retroviruses; 2010 Aug; 26(8):861-4. PubMed ID: 20672999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.